Vifor Pharma AG

Pharmaceuticals
Switzerland
2016 Revenue (US$ Millions)$4,200
Revenue Growth (%)8.37%
Net Income (US$ Millions)$239
Earnings Per Share (US$)$36.90
EPS Growth Rate (%)-19.02%
Profit Margin5.70%
Total Equity (US$ Millions)$2,087
Return on Equity (%)12.97%
Long Term Debt (US$ Millions)$270
Debt To Equity Ratio (%)0.13%
Total Assets (US$ Millions)$5,336
Current Assets (US$ Millions)$1,364
Current Liabilities (US$ Millions)$2,591
Cost of Goods Sold (US$ Millions)$2,449
Inventory Turnover6.11